Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Rhabdoid Tumor 1Neoplasms 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Advanced Liver Cancers 1

Interventions

Carboplatin 73pembrolizumab 70Pemetrexed 63Cisplatin 48Paclitaxel 27Nivolumab 27durvalumab 25osimertinib 24Specimen Handling 24Docetaxel 24Magnetic Resonance Spectroscopy 20Gemcitabine 18atezolizumab 15130-nm albumin-bound paclitaxel 15amivantamab 14Cetuximab 14lazertinib 11Radiotherapy 11Radiosurgery 11Bevacizumab 10Ipilimumab 9cemiplimab 8Taxes 8alectinib 7Ramucirumab 7Observation 7Drug Therapy 7Radiation 6Leucovorin 6Fluorouracil 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Tiragolumab × 30 days × Clear all
NCT04513925 2026-06-03

SKYSCRAPER-03

Hoffmann-La Roche

Phase 3 Completed
829 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04619797 2026-06-03

SKYSCRAPER-06

Hoffmann-La Roche

Phase 2/3 Completed
542 enrolled 28 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03337698 2026-05-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Terminated
314 enrolled 31 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡